DIRECTOR DEALINGS: Shield Therapeutics Medical Chief Buys Shares

Fri, 26th Apr 2019 18:19

LONDON (Alliance News) - Shield Therapeutics PLC said on Friday that Chief Medical Officer Mark Sampson and his wife Julia have purchased shares in the company on Thursday.

Mark bought 22,875 shares at a price of 87.5 pence per share, for a total of GBP20,015. Meanwhile, Julia acquired 22,042 shares for 90.7p each, worth GBP19,992.

Following these transactions, the Sampsons now hold 83,701 shares in the iron deficiency-focused pharmaceutical firm.

Shares in Shield Therapeutics closed 2.3% higher at 90.50p on Friday.

Related Shares

More News

30 Apr 2024 19:54

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

23 Apr 2024 14:26

UK earnings, trading statements calendar - next 7 days

21 Feb 2024 16:57

LONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors anxiously look ahead to this evening's Federal Open Market Committee ...

21 Feb 2024 12:36

Shield Therapeutics sinks as strong performance marred by data issues

(Alliance News) - Shield Therapeutics PLC on Wednesday said that it was expecting stellar results for 2023, but this success was overshadowed by a mis...

9 Jan 2024 11:33

IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO

Shield Therapeutics PLC - Commercial-stage pharmaceutical company focused on iron deficiency product Accrufer - Hires Santosh Shanbhag as chief financ...